Emerging issues related to COVID-19 vaccination in patients with cancer

Antibody-drug conjugates, immune-checkpoint inhibitors, and their combination in breast cancer therapeutics

Labcorp and Community Clinical Oncology Research Network Collaborate to Assess Social and Economic Impacts of Disparities in Cancer Care

BURLINGTON, N.C. & EDISON, N.J. --(BUSINESS WIRE)--Aug. 19, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, and Community Clinical Oncology Research Network, LLC (CCORN), a leading research organization, today announced their collaboration to better understand the impact of disparities in precision medicine for people with cancer. Information gathered from a patient registry and biobank will be used to help design future cancer clinical trials in diverse populations.

Mortality in adult patients with solid or hematological malignancies and SARS-CoV-2 infection with a specific focus on lung and breast cancers: A systematic review and meta-analysis

Labcorp extends leadership in women’s health with acquisition of Ovia Health

BURLINGTON, N.C. --(BUSINESS WIRE)--Aug. 12, 2021-- Labcorp (NYSE: LH), a leading global life sciences company, today announced that it has acquired Ovia Health , a digital health platform used by millions of women seeking information and support with family planning, pregnancy and parenting.